Struggling to find Bijuva at your pharmacy? Learn why this menopause hormone therapy is hard to find in 2026 and what you can do to get your prescription filled.
If you've been searching pharmacy after pharmacy for Bijuva, you're not imagining things. Many women dealing with menopause symptoms have run into the same problem — their doctor prescribed Bijuva, but when they go to fill it, the pharmacy doesn't have it in stock.
This is frustrating, especially when you're counting on this medication to manage hot flashes and other symptoms that disrupt your daily life. Let's look at why Bijuva is so hard to find in 2026 and, more importantly, what you can do about it.
Bijuva is a prescription medication that combines two bioidentical hormones — Estradiol (an estrogen) and Progesterone — in a single oral capsule. It was approved by the FDA in October 2018 for the treatment of moderate to severe hot flashes (vasomotor symptoms) caused by menopause in women who still have a uterus.
What makes Bijuva unique is that it's the first and only FDA-approved combination of bioidentical estradiol and bioidentical progesterone in one pill. Before Bijuva, women who wanted bioidentical hormones typically had to take two separate medications or rely on compounded preparations. You can learn more about how the medication works in our guide on how Bijuva works.
There are several reasons why you might be having trouble locating Bijuva at your local pharmacy.
As of 2026, there is no generic version of Bijuva available. That means only one manufacturer — Mayne Pharma — produces it. When a drug has no generic competition, the supply chain is more fragile. Any disruption in manufacturing, packaging, or distribution can lead to shortages at the pharmacy level.
Because Bijuva is a specialty brand-name product with a relatively high cash price ($257 to $351 for a 30-day supply), many pharmacies — especially large retail chains — don't keep it regularly in stock. Pharmacies tend to stock medications that move quickly, and a niche brand-only hormone therapy doesn't always make the cut.
The commercial rights for Bijuva transferred from TherapeuticsMD to Mayne Pharma in 2022–2023. Ownership transitions like this can cause temporary supply hiccups as new distribution networks are established. While the transition is largely complete, some supply inconsistencies have lingered in certain regions.
Interest in bioidentical hormone therapy has surged in recent years. More women are asking their doctors about FDA-approved bioidentical options like Bijuva instead of compounded alternatives. This increased demand can outpace the supply that's available at individual pharmacies.
For the latest information on supply, check out our Bijuva shortage update for 2026.
The good news is that Bijuva is not gone — it's just harder to track down. Here are some practical steps you can take.
Instead of calling pharmacy after pharmacy, use Medfinder to search for pharmacies near you that have Bijuva in stock. It saves you time and frustration by showing you real-time availability information.
Independent and specialty pharmacies are often more willing to order niche brand-name medications like Bijuva. They may also have better relationships with specialty distributors. If the big chains keep coming up empty, try a local independent pharmacy.
If your regular pharmacy doesn't have Bijuva on the shelf, ask them to order it for you. Most pharmacies can get brand-name medications within 1 to 3 business days through their wholesale distributor. You may just need to plan ahead and not wait until you're completely out.
Some insurance plans have preferred mail-order pharmacies that may carry Bijuva more reliably. Specialty pharmacies that focus on women's health or hormone therapy may also be a good option.
If you truly cannot find Bijuva, ask your prescriber about alternatives to Bijuva. Options like Prempro, Activella, or even separate estradiol and progesterone prescriptions may be easier to find.
Cost can also be a barrier to access. Without insurance, Bijuva typically costs between $257 and $351 for 30 capsules. However, the manufacturer offers a copay savings card that can bring the cost down to as little as $35 per month for commercially insured patients or $75 per month for cash-paying patients.
For more ways to save, read our guide on how to save money on Bijuva in 2026.
Being unable to find your menopause medication is stressful — but you have options. Bijuva's limited availability in 2026 is mostly due to it being a brand-only product with no generic, combined with growing demand and uneven pharmacy stocking. By using tools like Medfinder, trying independent pharmacies, and working with your doctor, you can improve your chances of getting the medication you need.
If you're still struggling, don't give up. Talk to your healthcare provider about your options, and check out our other resources on how to find Bijuva in stock near you.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
